This paper is only available as a PDF. To read, Please Download here.
Indirect observations suggest that the dopaminergic system may be involved in the
pathophysiology of obsessive—compulsive disorder (OCD). The dopaminergic function
of 15 patients with OCD and 15 age/sex-matched controls was evaluated by measuring
the growth hormone (GH) responses to stimulation with the dopaminergic agonist apomorphine
(APO), which increases growth hormone-releasing hormone (GHRH), GH, and somatomedine
C (SMD-C) secretions. Therefore, we measured basal plasma GH and SMD-C concentrations
and GH responses to GHRH stimulation to exclude that a downstream pathology of the
somatotropic axis could obscure the significance of the results of the APO test. The
response of prolactin (PRL) to APO inhibition were also measured. Basal plasma levels
of GH, SMD-C, and PRL, GH responses to GHRH stimulation, and PRL responses to APO
inhibition did not differ in the two groups of subjects. GH responses to APO stimulation
were blunted in obsessive—compulsive (OC) patients. The emetic response to the same
stimulation was stronger in patients than in controls. These responses suggest that
in our OC patients there is a dysregulation of the dopaminergic system, which is possibly
expressed in different ways in the various areas of the central nervous system.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Frontal lobe dysfunction in schizophenia and obsessive-compulsive disorder: A neuropsychological study.Brain Cogn. 1995; 27: 202-212
- CSF somatostin in obsessive-compulsive disorder.Am J Psychiatry. 1993; 150: 460-464
- Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.Arch Gen Psychiatry. 1994; 51: 794-803
- Massive doses of trifluoperazine in the treatment of compulsive rituals.Am J Psychiatry. 1962; 19: 376-379
- Diagnostic and Statistical Manual for Mental Disorders.3rd ed rev. American Psychiatry Press, Hillsdale, NJ1987
- Plasma catecholamines and their metabolites in obsessive compulsive disorder.Psychiatry Res. 1991; 37: 321-332
- Influence d'un traitement chronique au GRF (1–21) ou au clenbuterol chez la brebis en fin gestation sur la activite' de l'axe somatotrope fetal et maternel.Ann Endocrinol (Paris). 1989; 50 ([abstract]): 256
- Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OH-DA pretreatment.Psychopharmacology (Berl). 1988; 83: 62-69
- Biogenic amine metabolite in Tourette syndrome.Ann Neurol. 1979; 6: 37-39
- Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration.Arch Gen Psychiatry. 1978; 35: 245-250
- Hereditary agoraphobia and obsessive compulsive behavior in relatives of patients with Gilles de la Tourette's syndrome.Br J Psychiatry. 1987; 151: 1229-1241
- Biochemical properties of CNS dopamine receptors.in: Meltzer HY Psychopharmacology: A Third Generation of Progress. Raven Press, Washington, DC1987: 257-264
- The role of forebrain dopamine systems in amphetamine induced steretyped behavior in the rat.Psychopharmacologia. 1974; 39: 345-357
- Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotoninergic afferences.Brain Res. 1987; 186: 1-7
- Neuroanatomy of Gilles de la Tourette's syndrome: Possible midbrain involvement.Arch Neurol. 1983; 40: 508-514
- D-2 agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements.Brain Res. 1989; 490: 225-267
- Experimental Psychoneuroendocrinology.Medi Press, New York1985
- Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder.J Affect Disord. 1994; 32: 97-104
- Obsessions and compulsions in Gilles de la Tourette's syndrome.Neurology. 1986; 36: 378-382
- Persistent amphetamine-induced compulsive rituals: Response to pyridoxine (B-6).Biol Psychiatry. 1981; 16: 583-587
- Oestradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Rattedn: Ein Tiermodellzur Untersuchung der geschlechtsspezifishen Unterschiede bei der Schizophrenie Fortsch.Neurol Psychiat. 1992; 60: 8-16
- Influence of menstrual cycle phase on the therapeutic response in schizophrenia.Biol Psychiatry. 1994; 36: 137-139
- The Yale-Brawn obsessive-compulsive scale: I. Development, use, and reliability.Arch Gen Psychiatry. 1989; 46: 1006-1011
- Beyond the serotonin hypothesis: A role for dopamine in some forms of obsessive compulsive disorder?.J Clin Psychiatry. 1990; 51: 36-43
- The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder.Int Clin Psychopharmacol. 1992; 7: 35-38
- Obsessive-compulsive symptomatology in children with Tourette's syndrome.J Am Acad Child Adolesc Psychiatry. 1987; 1: 69-73
- Compulsive hoarding.Am J Psychother. 1987; 41: 409-416
- An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for psychiatry.Psychiatry Res. 1991; 38: 125-134
- Dietary protein restriction impairs both spontaneous and growth hormone-releasing factor-stimulated growth hormone release in the rat.Endocrinology. 1993; 133: 1035-1043
- Conceptual and methodological issues in studies of obsessive-compulsive and Tourette's disorders.Psychiatr Dev. 1989; 4: 276-296
- Effects of fenfluramine on HVA in OCD and controls.Biol Psychiatry. 1991; 29: 140A
- Effects of fenfluramine on plasma HVA in OCD.Psychiatry Res. 1992; 42: 185-188
- Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa.Behav Neurosci. 1985; 99: 531-545
- Gilles de la Tourette syndrome after long-term chlorpromazine therapy.Neurology. 1978; 28: 1064-1066
- Obsessive compulsive symptoms following stimulants.Biol Psychiatry. 1985; 20: 1332-1337
- Damphetamine in obsessive-compulsive disorder.Psychopharmacology (Berl). 1983; 80: 231-235
- Encephalitis lethargica, a contemporary causes of catatonic stupor, a report of two cases.Br J Psychiatry. 1987; 151: 550-552
- Apomorphine in the evaluation of dopaminergic function in man.Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12: 117-164
- Cerebrospinal fluid biogenic amines in obsessive-compulsive disorder, Tourette's syndrome and healthy controls.Neuropsychopharmacology. 1985; 12: 73-86
- Stimulant medications precipitate Tourette's syndrome.JAMA. 1982; 247: 1729-1731
- Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.Psychiatry Res. 1992; 42: 41-52
- The effect of glucose on growth hormone (GH) releasing hormone-mediated GH secretion in man.J Clin Endocrinol Metab. 1985; 60: 523-526
- Neuroleptic addition in fluvoxamine-refractory obsessive compulsive disorder.Am J Psychiatry. 1990; 147: 652-654
- Haloperidol addition in fluvoxaminerefractory obsessive-compulsive disorder.Arch Gen Psychiatry. 1994; 51: 302-308
- Cocaine and Tourette' syndrome.N Engl J Med. 1978; 315: 398
- Neurophysiologic dysfunction in basal ganglia/limbic striatal and talamocortical circuits as a pathogenetic mechanism of obsessive compulsive disorder.J Neuropsychiatry. 1989; 1: 27-36
- Neural control of somatotropic function.Physiol Rev. 1987; 3: 962-1053
- Brain Messengers and the Pituitary.Academic Press, Goteborg, Sweden1989
- Schizophrenia.Wiley, New York1988
- Gilles de la Tourette's syndrome and obsessive compulsive disorder: Evidence supporting a genetic relationship.Arch Gen Psychiatry. 1986; 43: 1180-1182
- A family study of Gilles de la Tourette syndrome.Am J Hum Genet. 1991; 48: 154-163
- Priming with GHRH (1–29)-NH-2 as a useful tool in the origin diagnosis of growth hormone (GH) deficiency.Acta Med Auxol. 1993; 25: 133-138
- Clinical comparison of Tourette's disorder and obsessivecompulsive disorder.Am J Psychiatry. 1987; 4: 267-296
- Obsessive-compulsive disorder: Evidence for basal ganglia dysfunction.Psychopharmacol Bull. 1988; 24: 380-384
- Further evidence for a specific role of estradiol in schizophrenia?.Biol Psychiatry. 1994; 36: 492-497
- Succesful treatment of obsessive compulsive disorder with cloxapine.Am J Psychiatry. 1982; 139: 1345-1346
- NIMH Diagnosis Interview Schedule: Version III-R.Washington University Medical School, New York1989
- Serum antibody for somatostin-14 and prodynorphin 209–240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis and advanced HIV infection.Biol Psychiatry. 1994; 35: 335-344
- Increased right caudate nucleus size in obsessive-compulsive disorder (OCD), detection with magnetic resonance imaging.Psychiatry Res Neuroimaging. 1992; 45: 115-121
- Dopamine D-2 receptors are restricted to the prolactin cells in rabbit pituitary gland: A combined autoradiographic and immunocytochemical study.Neurosci Lett. 1986; 70: 314-319
- Dopamine receptors pharmacology.Curr Opin Neurol Neurosurg. 1993; 6: 602-608
- Evaluation of the reported association of obsessive-compulsive symptoms or disorder with Tourette's disorder.Compr Psychiatry. 1992; 33: 156-165
- Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome.Arch Gen Psychiatry. 1989; 46: 722-730
- Molecular biology of dopamine receptors.Trends in Pharmacological Sciences. 1992; 13: 61-69
- Dopaminergic disfunction in Tourette syndrome.Ann Neurol. 1982; 12: 361-366
- Abnormal dopamine uptake sites in post-mortem striatum from patients with Tourette's syndrome.Ann Neurol. 1991; 30: 558-562
- A review of the GHRH stimulation test in psychiatry.Biol Psychiatry. 1994; 36: 249-265
- Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.Arch Gen Psychiatry. 1992; 49: 29-36
- A study of clinical pictures and monoamino metabolism of Gilles de la Tourette syndrome.Psychiatr Neurol Japanica. 1993; 95: 1-29
- Clomipramine treatment of obsessive compulsive disorders: II. Biochemical aspects.Arch Gen Psychiatry. 1980; 37: 1289-1294
- Drug-induced stereotyped behavior: Similarities and differences.in: Usdin E Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes. Raven Press, St. Louis1974: 241-260
- Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.J Clin Endocrinol Metab. 1991; 72: 374-381
- Impaired growth hormone responses to growth hormone-releasing factor in obesity.N Engl J Med. 1984; 211: 1403-1407
- Obsessive compulsive disorder: Is it basal ganglia dysfunction?.in: Rapoport JL Obsessive Compulsive Disorder in Children and Adolescents. America Psychiatric Press, New York1989: 327-344
Article Info
Publication History
Received in revised form:
October 2,
1996
Received:
June 10,
1996
Identification
Copyright
© 1997 Society of Biological Psychiatry. Published by Elsevier Inc.
